BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 35311433)

  • 1.
    Sekar V; Ramasamy G; Ravikumar C
    Drug Dev Ind Pharm; 2022 May; 48(5):169-188. PubMed ID: 35311433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticancer Potential of Hydroxychavicol Derived from
    Vinusri S; Gnanam R; Caroline R; Santhanakrishnan VP; Kandavelmani A
    Nutr Cancer; 2022; 74(10):3701-3713. PubMed ID: 35703834
    [No Abstract]   [Full Text] [Related]  

  • 3. Phytochemical Analysis, Identification and Quantification of Antibacterial Active Compounds in Betel Leaves, Piper betle Methanolic Extract.
    Syahidah A; Saad CR; Hassan MD; Rukayadi Y; Norazian MH; Kamarudin MS
    Pak J Biol Sci; 2017; 20(2):70-81. PubMed ID: 29022997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydroxychavicol: a potent xanthine oxidase inhibitor obtained from the leaves of betel, Piper betle.
    Murata K; Nakao K; Hirata N; Namba K; Nomi T; Kitamura Y; Moriyama K; Shintani T; Iinuma M; Matsuda H
    J Nat Med; 2009 Jul; 63(3):355-9. PubMed ID: 19387769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro antifungal activity of hydroxychavicol isolated from Piper betle L.
    Ali I; Khan FG; Suri KA; Gupta BD; Satti NK; Dutt P; Afrin F; Qazi GN; Khan IA
    Ann Clin Microbiol Antimicrob; 2010 Feb; 9():7. PubMed ID: 20128889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new hydroxychavicol dimer from the roots of Piper betle.
    Lin CF; Hwang TL; Chien CC; Tu HY; Lay HL
    Molecules; 2013 Feb; 18(3):2563-70. PubMed ID: 23442932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Betelvine (Piper betle L.): A comprehensive insight into its ethnopharmacology, phytochemistry, and pharmacological, biomedical and therapeutic attributes.
    Biswas P; Anand U; Saha SC; Kant N; Mishra T; Masih H; Bar A; Pandey DK; Jha NK; Majumder M; Das N; Gadekar VS; Shekhawat MS; Kumar M; Radha ; Proćków J; Lastra JMP; Dey A
    J Cell Mol Med; 2022 Jun; 26(11):3083-3119. PubMed ID: 35502487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The underlying mechanism of action for various medicinal properties of Piper betle (betel).
    Haslan H; Suhaimi FH; Thent ZC; Das S
    Clin Ter; 2015; 166(5):208-14. PubMed ID: 26550811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory potential of Hydroxychavicol on Ehrlich ascites carcinoma model and
    Hemamalini V; Velayutham DPM; Lakshmanan L; Muthusamy K; Sivaramakrishnan S; Premkumar K
    Nat Prod Res; 2020 Jun; 34(11):1591-1596. PubMed ID: 30470141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The new ether derivative of phenylpropanoid and bioactivity was investigated from the leaves of
    Atiya A; Sinha BN; Lal UR
    Nat Prod Res; 2020 Mar; 34(5):638-645. PubMed ID: 30169967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Piper betle leaves: profiling phenolic compounds by HPLC/DAD-ESI/MS(n) and anti-cholinesterase activity.
    Ferreres F; Oliveira AP; Gil-Izquierdo A; Valentão P; Andrade PB
    Phytochem Anal; 2014; 25(5):453-60. PubMed ID: 24733630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydroxychavicol, a polyphenol from
    Rajedadram A; Pin KY; Ling SK; Yan SW; Looi ML
    J Zhejiang Univ Sci B; 2021 Feb; 22(2):112-122. PubMed ID: 33615752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydroxychavicol, a key ingredient of Piper betle induces bacterial cell death by DNA damage and inhibition of cell division.
    Singh D; Narayanamoorthy S; Gamre S; Majumdar AG; Goswami M; Gami U; Cherian S; Subramanian M
    Free Radic Biol Med; 2018 May; 120():62-71. PubMed ID: 29550331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening of growth inhibitors for epithelial-mesenchymal transition-induced cells by TGF-β from plant-based sources identified the active compound hydroxychavicol from Piper bitle.
    Matsuo H; Kawakami H; Anjiki N; Kawano N; Fuchino H; Kawahara N; Yoshimatsu K
    J Nat Med; 2024 Jun; 78(3):774-783. PubMed ID: 38418720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phenylpropanoid dimer from the leaves of
    Atiya A; Majrashi TA; Begum MY; Lal UR; Sinha BN; Qadira SFA
    Nat Prod Res; 2023 May; 37(9):1550-1556. PubMed ID: 35232302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth inhibitory response and ultrastructural modification of oral-associated candidal reference strains (ATCC) by Piper betle L. extract.
    Nordin MA; Wan Harun WH; Abdul Razak F; Musa MY
    Int J Oral Sci; 2014 Mar; 6(1):15-21. PubMed ID: 24406634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the antimicrobial, antioxidant, and anti-inflammatory activities of hydroxychavicol for its potential use as an oral care agent.
    Sharma S; Khan IA; Ali I; Ali F; Kumar M; Kumar A; Johri RK; Abdullah ST; Bani S; Pandey A; Suri KA; Gupta BD; Satti NK; Dutt P; Qazi GN
    Antimicrob Agents Chemother; 2009 Jan; 53(1):216-22. PubMed ID: 18573934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Betel leaf extract and its major component hydroxychavicol promote osteogenesis and alleviate glucocorticoid-induced osteoporosis in rats.
    Mishra R; Das N; Varshney R; Juneja K; Sircar D; Roy P
    Food Funct; 2021 Jul; 12(14):6603-6625. PubMed ID: 34105538
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Nayaka NMDMW; Sasadara MMV; Sanjaya DA; Yuda PESK; Dewi NLKAA; Cahyaningsih E; Hartati R
    Molecules; 2021 Apr; 26(8):. PubMed ID: 33923576
    [No Abstract]   [Full Text] [Related]  

  • 20. Bio-actives of betel leaf (Piper betle L.): A comprehensive review on extraction, isolation, characterization, and biological activity.
    Madhumita M; Guha P; Nag A
    Phytother Res; 2020 Oct; 34(10):2609-2627. PubMed ID: 32524688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.